For the attention of Community Pharmacies providing vaccination services and/or needle exchange services
Dear Contractor
CPNI and SPPG are in the process of identifying the numbers of staff who require Hepatitis B vaccination due to participation in vaccination and/or needle exchange services.
CPNI are requesting Contractors to please fill in the survey to collate the numbers of staff that require Hepatitis B vaccination.
To avoid duplication for those pharmacists that provide services to both vaccinations and needle exchange, and who require Hepatitis B vaccination, please only submit numbers on the vaccination services question.
CPNI appreciates Contractors taking the time to fill out this survey and requests returns to be submitted by Friday 17th November 2023.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
Correspondence was issued by SPPG on 09 November 2023 to advise pharmacy contractors of the recommencement of Community Pharmacy Assurance Framework (CPAF) visits. The correspondence can be viewed here.
SUMMARY
CPAF consists of an annual declaration completed by each community pharmacy contractor, and a visit undertaken by SPPG staff.
The overall aim and purpose is to monitor compliance with the Terms of Service, service specifications, related professional standards and best practice guidance.
Information on the Community Pharmacy Assurance Framework, including the visit protocol and guidance is available on the BSO website here.
The SPPG letter advises that visits will be recommencing, and that pharmacies which have never received a visit as part of CPAF, will be prioritised.
If your pharmacy is selected for a visit you will be contacted by your local office to make the necessary arrangements.
ACTIONS
Contractors should note the contents of the SPPG letter and share the information with relevant members of the pharmacy team.
Should contractors have any queries regarding CPAF they may wish to contact their local SPPG pharmacy adviser, or alternatively they may contact a member of the CPNI team.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
For the attention of Community Pharmacies providing the Autumn 2023 COVID-19 and Seasonal Influenza Community Pharmacy Vaccine Service (CPVS)
Dear Contractor
The following communication was issued 08.11.23 by SPPG to those pharmacies involved in the community pharmacy vaccination service. Please ensure this information is shared with relevant members of your pharmacy team.
Urgent Reminder: Declaration of Completion of Care Home Vaccinations by 31St October 2023: Claim for additional £200 payment
As per the COVID-CPVS service specification community pharmacies are reimbursed an additional £200 fee where vaccination of residents of a Care Home has been fully completed by 31st October 2023.
Each of the care home(s) completed by 31st October should be selected from the drop-down list. Contractors are asked make a single return selecting multiple care homes where required.
If you have any queries relating to this declaration please contact Tom Coyle (Tom.Coyle@hscni.net).
If you have any queries please do not hesitate to contact a member of the CPNI team.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
Northern Ireland’s Chief Medical Officer issued correspondence on 07 November 2023 which includes information on the MHRA Drug Safety Update on Valproate dispensing. The CMO’s letter is available here.
SUMMARY
The CMO’s letter of 07 November 2023 includes information relating to the MHRA Drug Safety Update on Valproate which can be accessed here.
The letter refers to earlier correspondence dated 12 October 2023 which can be accessed here.
Contractors will be aware that information relating to Valproate dispensing was issued by SPPG on 31 October 2023, which can be accessed here.
ACTION
Contractors are asked to:
Review the correspondence referred to above and to ensure that relevant members of their pharmacy team are aware of the content.
If you have any queries please do not hesitate to contact a member of the CPNI team.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
CPNI have been advised that a licensed version of Omeprazole 1mg/1ml oral suspension sugar free (75ml) with a list price of £111.00 was recently launched in the market by Rosemont Pharmaceuticals Ltd.
SUMMARY
BSO have allocated a new code for this product, 98740, and this code should be used for all prescriptions for Omeprazole 1mg/ml oral suspension sugar free from November 2023 prescriptions onwards.
The Northern Ireland Drug Tariff has designated that this product is a special container.
CPNI have confirmed with BSO that this product will have zero discount (ZD) status.
The full correspondence released by BSO on Friday 03.11.23 can be found here
ACTION
Contractors should read the correspondence issued by BSO here
The new code 98740, should be used for all prescriptions for Omeprazole 1mg/ml oral suspension sugar free from November 2023 onwards
If you have any queries, please contact Mark Nelson on mark.nelson@hscni.net
CPNI colleagues are also available for assistance.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
SPPG have released an important update letter which has been uploaded to the BSO website regarding the Living Well service.
SUMMARY
A letter for the attention of Living Well Pharmacies has been issued by SPPG to the BSO website and can be accessed here
Living Well information on current and recent campaigns can be accessed here
ACTION
Contractors who provide the Living Well Service should ensure that they read and review the letter issued 06.11.23
The survey for Childhood Immunisations is currently available and can be completed here
For any queries in relation to the Living Well service, please contact katie.blair@hscni.net.
CPNI colleagues are also available for assistance required.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
